StockData
SL Science Holding Ltd logo

SL Science Holding Ltd (SLBT) shareholders

SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.64−0.08 (-11.73%)

Close on Nov 17, 2026Market cap $356.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1M
Shares held, 13F filers
Institutional holders
8
8 new, 0 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $10.33T

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Ching-Dong Wang
Joint filing with SL Link Holding Ltd. (58.72%)
333,832,12959.53%13D (active) amendmentSep 29, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SLBTValueChange% of portfolio
Geode Capital Management, LLC193,404–$926.41KNew0.00%
L1 Global Manager Pty Ltd150,000–$718.50KNew0.51%
Rivernorth Capital Management, LLC130,000–$622.70KNew0.03%
Heights Capital Management, Inc20,000–$95.80KNew0.02%
Lynx Capital Group Ltd /Adv17,096–$81.89KNew0.03%
Jane Street Group, LLC14,540–$69.65KNew0.00%
UBS Group AG12,515–$59.95KNew0.00%
Osaic Holdings, Inc.286–$1.37KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202681M8 / 00 / 01M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Chin-Sheng HungChief Medical Officer, Director–Nov 6, 2026
Ching-Dong WangChief Executive Officer, Director, 10% owner333,832,129Oct 1, 2026
Lok Sang LeungChief Financial Officer–Jun 16, 2026
Qian XuDirector20,000Jun 17, 2026
John Conrad GeneralDirector–Jun 16, 2026
Mingche LiuDirector–Jun 16, 2026
Kwo-Liang ChenDirector–Jun 16, 2026
Joseph LevinsonDirector–Jun 15, 2026
Ethan Shen PhD––Nov 3, 2026
Johnson Shun-Pong Lau––Sep 1, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ching-Dong Wang
Chief Executive Officer, Director, 10% owner
Sep 29, 2026Buy+4,545,306$2272653.00$10.33T333,832,129

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.02%
0M shares short
Days to cover
1.4
At 0M shares a day
Change since last report
+36.6%
From 0M shares
Short volume, 20 days
43.0%
Of volume reported to FINRA

Shares sold short, last 5 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of SL Science's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,646 shares on Sep 28, 2026 over the last 90 days.

See a number that looks wrong?